The deal priced at last closing price of $161.33. Goldman Sachs is acting as lead book running manager for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KRTX:
- Karuna Therapeutics announces $400M offering of common stock
- Karuna Therapeutics Down Even after Positive Topline Results
- Karuna Therapeutics announces ‘positive’ results from Phase 3 EMERGENT-3 trial
- Sell these stocks now, proven algorithm says
- Karuna says maintains ‘de minimis amount’ of cash, equivalents with SVB
